Drug · DIN 02452162
CEFAZOLIN FOR INJECTION
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 28, 2024; first marketed July 27, 2016.
- Drug Identification Number (DIN)
- 02452162
- Company (DIN owner)
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Cefazolin J01DB04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEFAZOLIN (CEFAZOLIN SODIUM) | 10 G | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 4, 2016: NOC 17840Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named CEFAZOLIN FOR INJECTION
- DIN 02108119 · Marketed
- DIN 02108127 · Marketed
- DIN 02437104 · Marketed
- DIN 02437112 · Marketed
- DIN 02437120 · Marketed
- DIN 02108135 · Cancelled Post Market